Cite

HARVARD Citation

    Mateos, M. et al. (n.d.). B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS. HemaSphere. p. 9. [Online]. 
  
Back to record